PO:35:234 | Sustained Vasculitis Quiescence and CS Reduction with Mepolizumab 100 mg: Francesca Mascia1, Angelo Fassio2, Marco Zurlo1, Davide Chesini3, Francesco Pollastri2, Giovanni Adami2, Davide Gatti4, Maurizio Rossini4, Matteo Maule5, Gianentrico Senna1, Marco Caminati1 | 1University of Verona - Allergology and Clinical Immunology Verona, Italy; 2Policlinico G. B. Rossi - Rheumatology Verona, Italy; 3University of Verona - Faculty of Medicine and Surgery Verona, Italy; 4University of Verona - Rheumatology Verona, Italy; 5Policlinico G. B. Rossi - Allergology and Clinical Immunology Verona, Italy. Reumatismo [Internet]. 2026 Mar. 18 [cited 2026 Apr. 17];77(s1). Available from: https://www.reumatismo.org/reuma/article/view/2387